HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Share Repurchase Likely: Health And Wellness Industry News Roundup

This article was originally published in The Rose Sheet

Executive Summary

$1.45m loan tees up Herbalife share repurchase; Tieraona Low Dog is Vitamin Shoppe's "chief wellnbeing ambassador"; Supplement OWL accepting label input; and more news in brief.

You may also be interested in...



Sale To Icahn Off Table, Herbalife Tenders $600m Share Repurchase

Herbalife commences a $600m share repurchase after discussion with Carl Icahn to take the company private ended. The move intensifies the battle between Icahn and Bill Ackman, who has bet $1bn that the direct sales firm will fail.

Protiva Distribution, Tinnistop Launches: Health And Wellness Industry News Roundup

Protiva supplements get Ascend distribution; Garden of Life plants flag in Sport; homeopathic for tinnitus launched; CRN, NPI extend webinar series; and more news in brief.

Herbalife Adds TCMs In JV: Health And Wellness Industry News Roundup

Herbalife adds traditional Chinese medicine to its portfolio as it reports 17.6% net income growth; PepsiCo's Naked Juice brand agrees to modify labeling in CSPI litigation; and House Health Subcommittee schedules hearing on improving sports' doping testing system.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel